• Zum Hauptinhalt springen
  • Zum Footer springen
  • Deutsch - de
  • English - en

    SyNergy - Mu...

    • About
      • About us
      • Our Measures
      • Members
      • Cluster Management
      •  PhD & Postdoc representatives
      • Scientific Advisory Board
      •  International cooperation partners
      • Timeline
      •  Media Kit
      • Contact
    • News & Events
      • News
      • Events
      • In the News
      • Open Positions
    • Research
      • Publications
      • Our Research Focus
      • Technology Hubs
      • Research Spotlight
      • Research Data Management
      • Sustainability Initiative
      •  Code of Conduct
    • Science & Society
      • For Schools & Students
      • Public Events
      • Podcasts
      • Videos
    • Support for Diversity & Equity
      • Newcomer Center
      • Gender Equality Program
      • Early Career Investigator Program
    1. Home
    2. News & Events
    3. News
    4. SyNergy‘s open day “Tag der nervenstarken Forschung” was a success!
    News | 17/06/2024 | Event Recap

    SyNergy‘s open day “Tag der nervenstarken Forschung” was a success!

    On Saturday, 8 June 2024, we hosted a public event called 'Tag der nervenstarken Forschung' to share our latest findings and insights into neurological diseases. The event, held in a lecture hall in Großhadern, Munich, attracted over 250 eager and curious individuals of all ages. This diverse audience had the opportunity to learn about our research on Alzheimer's, Parkinson's, Multiple Sclerosis (MS), and stroke through engaging lectures, information booths, and question rounds. The overwhelmingly positive feedback we received underscored the importance of such events for the general public and highlighted how the event contributed to the audience’s knowledge and understanding.
    Fabian Vogl
    Welcome by Thomas Misled

    The event began with a speech by our speaker, Prof Thomas Misgeld, who explained how SyNergy research goes beyond traditional boundaries of neurological diseases and is based on interdisciplinary collaborations. Dr Lisa Ann Gerdes started her presentation by sharing the results of her MS TWIN study with identical twins giving valuable insights in the course of Multiple Sclerosis. Prof Lena Burbulla then presented her research and very recent progress on Parkinson's disease. After a short coffee break, Prof Christian Haass addressed the question: "Will we ever cure Alzheimer’s?" This was followed by a presentation by Prof Martin Dichgans on stroke and the latest research by Prof Anna-Sophia Wahl on the remarkable self-healing abilities of the brain after damage. Graphic recorder Beate Kopp visually summarized the event's key messages (see below).


    History of Medicine: Brain samples from the first Alzheimer’s Patient

    During the breaks, participants had the unique opportunity to view original brain samples from the very first Alzheimer’s patient, Auguste Deter, under a microscope. Alois Alzheimer, her treating physician, who prepared these samples, first reported on her case in 1906 at the 37th meeting of the Southwest German Society of Psychiatrists. These historic samples have been hidden in the archives for a long time and were seldom exhibited to the public.


    Collaboration with Partners

    Visitors could learn more about our research topics and structures, such as our Technology Hubs, through posters and information materials and chat with representatives of clinical and patient organizations. Including the Outpatient Clinic of the Institute for Stroke and Dementia Research (ISD), the Munich Alzheimer Association (Alzheimer Gesellschaft München), and the MS Mentoring Program (MS Patenprogramm).


    Keeping it short and sweet: research in 400 seconds

    Five of our young investigators presented their research in as little as 400 seconds in the afternoon. Lis de Weerd from the lab of Prof Haass explained how we could use the body’s own immune system to fight Alzheimer’s disease by focusing on strengthening the microglia. Carolin Meyer from Prof Herms’ lab shared her research project on the relationship between smell dysfunction and Alzheimer’s disease – and how smell disorder could be an early warning signal of Alzheimer’s disease. Theresa Niedermeier, also from the Herms lab, explained the role of mitochondria and its dysfunction in Alzheimer. The research of Aida Cardona-Alberich from Prof Burbulla’s lab is about RNA and how it functions as a blueprint for healthy neurons by giving correct instructions for protein production. Finally, Felix Waitzmann from Prof Julijana Gjorgjieva’s lab discussed neuronal representations of language after a stroke. All presentations were accompanied by lively examples and metaphors, helping the audience to better understand the pioneering research.

    The event concluded with a question round, allowing all participants to ask the scientists their final questions.

    Photo gallery

    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl
    • Fabian Vogl

    Participating Universities
     LMU logo in white
     TUM logo in white
    Partner Institutions
     Logo DZNE in white
    Helmholtz Munich logo in white 
     Logo Max Planck Gesellschaft 

    SyNergy is funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the German Excellence Strategy (EXC 2145 SyNergy – ID 390857198). The Excellence Strategy promotes outstanding research at German universities. 

    Contact

    Munich Cluster for Systems Neurology (SyNergy)

    Feodor-Lynen-Str. 17
    81377 Munich
    +49 (0)89 4400-46497
    yüubgybYcјuipxј_vfulyzWemi
    Editor login
    Imprint | Data-Safety